Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep 19:7:25382.
doi: 10.3402/gha.v7.25382. eCollection 2014.

Fifteen-year trend in treatment outcomes among patients with pulmonary smear-positive tuberculosis and its determinants in Arsi Zone, Central Ethiopia

Affiliations

Fifteen-year trend in treatment outcomes among patients with pulmonary smear-positive tuberculosis and its determinants in Arsi Zone, Central Ethiopia

Shallo D Hamusse et al. Glob Health Action. .

Abstract

Background: Directly Observed Treatment Short course (DOTS) strategy is aimed at diagnosing 70% of infectious tuberculosis (TB) and curing 85% of it. Arsi Zone of Ethiopia piloted DOTS strategy in 1992. Since then, the trend in treatment outcomes in general and at district-level in particular has not been assessed. The aim of this study was to analyse the trend in TB treatment outcomes and audit district-level treatment outcomes in the 25 districts of Arsi Zone.

Design: A retrospective cohort study design was employed to audit pulmonary smear-positive (PTB + ) patients registered between 1997 and 2011. Demographic and related data were collected from the TB unit registers between January and March 2013. The 15-year trend in treatment outcomes among PTB+ patients and district-level treatment outcomes was computed.

Results: From 14,221 evaluated PTB+ cases, 11,888 (83.6%) were successfully treated. The treatment success rate (TSR) varied from 69.3 to 92.5%, defaulter rate from 2.5 to 21.6%, death rate from 1.6 to 11.1%, and failure rate from 0 to 3.6% across the 25 districts of the zone. The trend in TSR increased from 61 to 91% with the increase of population DOTS coverage from 18 to 70%. There was a declining trend in defaulter rate from 29.9 to 2.1% and death rate from 8.8 to 5.4% over 15 years. Patients aged 25-49 years (Adjusted Odd Ratio (AOR), 0.23; 95% CI: 0.21-0.26) and ≥50 years (AOR, 0.43; 95% CI: 0.32-0.59), re-treatment cases (AOR, 0.61; 0.41, 0.67), and TB/HIV co-infection cases (AOR, 0.45; 95% CI: 0.31-0.53) were associated with unsuccessful treatment outcomes.

Conclusions: DOTS expansion and improving population DOTS coverage in Arsi has led to a significant increase in treatment success and decrease in death and defaulter rates. However, there is a major variation in treatment outcomes across the 25 districts of the zone, so district-specific intervention strategy needs to be considered. The low TSR among re-treatment cases might be due to the high rate of MDR-TB among this group, and the issue needs to be further investigated to identify the extent of the problem.

Keywords: Arsi Zone; Ethiopia; treatment outcomes; trends; tuberculosis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Profile for pulmonary smear-positive TB patients registered during 1997–2011 and treatment outcomes, Arsi Zone, Central Ethiopia.
Fig. 2
Fig. 2
Trends in TB treatment outcomes and population DOTS coverage, Arsi Zone, Central Ethiopia, 1997–2011. Note: Trends in treatment success rate of PTB+ increased (X2trend = 31.08, p<0.001) with declined in death rate (X2trend=18.56, p<0.001) and defaulter rate (X2trend=33.74, p<0.001) over time. Trends in treatment success rate increased; death rate and defaulter rate declined with increase of DOTS population coverage (X2trend=22.243, p<0.001).

Similar articles

Cited by

References

    1. World Health Organization. World Health Organization global tuberculosis control. Geneva: World Health Organization; 2011.
    1. Raviglione M, Marais B, Floyd K, Lönnroth K, Getahun H, Migliori GB, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet. 2012;379:1902–13. - PubMed
    1. Lia D, Antonio S, Rosella C. Epidemiology of tuberculosis. Eur Respir J. 2012;58:1–13.
    1. Migliori GB, Sotgiu G, Lange C, Centis R. Extensively drug-resistant-tuberculosis: back to the future. Eur Respir J. 2010;36:1–3. - PubMed
    1. Yassin MA, Datiko DG, Shargie EB. Ten-year experiences of the tuberculosis control programme in the southern region of Ethiopia. Int J Tuberc Lung Dis. 2006;10:1166–71. - PubMed

MeSH terms

Substances

LinkOut - more resources